Inogen
INGN
Inogen (INGN) news
Recent news
Guangzhou InnoGen Pharmaceutical Group Co Ltd - Intention to conduct on-market H share repurchase
On August 11, 2026, the Board of Directors of Guangzhou InnoGen Pharmaceutical Group Co Ltd authorized a buyback plan, signaling intention to repurchase shares on the open market. While the specific financial terms of the repurchase program have not been disclosed, the move reflects the company’s…
AInvest Wire · 5d agoInogen Q2 EPS USD -0.14
AInvest Wire · Aug 6, 2026Inogen, Inc. Q2 SHR view $-0.15 -- LSEG IBES data
AInvest Wire · Aug 6, 2026Inogen - updates FY2026 revenue guidance to $355 mln-$361 mln
AInvest Wire · Aug 6, 2026Inogen raises FY2026 adj EBITDA guidance to about $4 mln
AInvest Wire · Aug 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.